Causes of False Positive NS1 Reports in Dengue Testing
False positive results in dengue NS1 antigen detection tests are primarily caused by cross-reactivity with other flaviviruses, though this typically requires substantially high viral titers of the cross-reacting virus. 1
Cross-reactivity with Other Flaviviruses
The most common cause of false positives in NS1 testing is cross-reactivity with other flaviviruses due to their similar antigenic profiles, particularly with:
Cross-reactivity occurs because flaviviruses share structural similarities in their nonstructural proteins, including NS1 3
Research shows that substantially high viral titers of Zika virus, Kunjin virus, and Yellow fever virus are required to produce false-positive results in commercial dengue NS1 rapid detection assays 1
Timing of Sample Collection
NS1 antigen is detectable from day 1 of symptom onset up to 10 days thereafter, with highest sensitivity in the first week of illness 4, 5
Testing outside this optimal window (especially after 7 days) may lead to unreliable results, including false positives 5
As antibodies develop (typically 3-5 days after symptom onset for IgM), they may form immune complexes with NS1, potentially affecting test results 6
Test-Related Factors
Different commercial NS1 detection assays have varying specificities and sensitivities:
The quality and design of the antibodies used in the assay significantly impact specificity 7
Clinical and Epidemiological Factors
Testing in areas with low prevalence of dengue but high prevalence of other flaviviruses may increase the likelihood of false positives due to the lower positive predictive value 2
Previous flavivirus infections or vaccinations (e.g., yellow fever vaccine) can potentially lead to cross-reactive immune responses that may interfere with NS1 testing 2
Recommendations for Minimizing False Positives
In areas where multiple flaviviruses co-circulate, consider using more specific ELISA-based NS1 tests rather than rapid tests 1
For definitive diagnosis in ambiguous cases, consider confirmatory testing with:
Interpret NS1 results in conjunction with clinical presentation and epidemiological context 4
When testing patients with previous flavivirus exposure, be aware of the increased risk of false positives and consider additional confirmatory testing 2